DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World Epigenetics Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
The key factors driving the growth of the world epigenetics market are increase in prevalence of cancer, improved funding for research & development activities, growth in partnership between academic, biotechnology & pharmaceutical companies, and increased application of non-oncology diseases. However, high cost of instruments and lack of trained professionals are the factors restraining the growth of this market.
The world epigenetics market is segmented based on product, research area, end user, and geography. The market is further segmented based on product into enzymes, instruments & consumables, kits, and reagents.
Furthermore, enzymes are classified into DNA-modifying enzymes (DNA ligases, DNA polymerases, and other DNA-modifying enzymes), protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes), and RNA-modifying enzymes (reverse transcriptase, RNA ligases, and other RNA-modifying enzymes).
The instruments & consumables are further segmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators, and other epigenetics instruments & consumables.
Kits are further classified into bisulfite conversion kits, RNA sequencing kits, ChIP-seq kits, 5-hmC & 5-mC analysis kits, whole genome amplification kits, and other epigenetics kits. Reagents are further classified into antibodies, primers, histones, magnetic beads, buffers, and other epigenetics reagents.
The world epigenetics market is further classified based on research areas into developmental biology, oncology, drug discovery, and other epigenetics research areas. The market is further divided based on end users into academic research institutes, biotechnology & pharmaceutical companies, and contract research organizations.
The leading manufacturers profiled in the report are Abcam, Illumina, Diagenode, New England Biolabs, Thermo Fisher Scientific, Sigma-Aldrich Corporation, Active Motif, Merck, Qiagen, and Zymo Research.
They have implemented strategies, such as mergers & acquisition, partnerships, expansion, and others to strengthen their position in the world epigenetics industry.
For more information about this report visit http://www.researchandmarkets.com/research/q4fd5h/world_epigenetics